Georgianna Maule-Ffinch 2015 Trust - Apr 10, 2023 Form 3 Insider Report for Better Therapeutics, Inc. (BTTX)

Role
10%+ Owner
Signature
/s/ Mark Heinen, Attorney-in-Fact for Georgianna Maule-Ffinch 2015 Trust
Stock symbol
BTTX
Transactions as of
Apr 10, 2023
Transactions value $
$0
Form type
3
Date filed
4/17/2023, 04:15 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BTTX Common Stock 3.64M Apr 10, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 6, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the "PIPE Investors") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.825 per share. As one of the PIPE Investors, the Reporting Person acquired 3,636,364 shares of Issuer common stock on April 10, 2023 for $0.825 per share.

Remarks:

Exhibit 24 - Power of Attorney